AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 19 filers reported holding AKARI THERAPEUTICS PLC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $516,000 | +57.3% | 46,622 | 0.0% | 0.10% | +21.5% |
| Q4 2016 | $328,000 | -17.4% | 46,622 | 0.0% | 0.08% | +23.4% |
| Q3 2016 | $397,000 | -36.9% | 46,622 | 0.0% | 0.06% | -64.8% |
| Q2 2016 | $629,000 | -3.7% | 46,622 | 0.0% | 0.18% | -50.8% |
| Q1 2016 | $653,000 | -4.4% | 46,622 | -1.0% | 0.37% | +32.1% |
| Q4 2015 | $683,000 | +40.0% | 47,116 | +131.8% | 0.28% | +27.3% |
| Q3 2015 | $488,000 | – | 20,325 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 178,091 | $703,459 | 0.52% |